Does Gastroscopy Induce Myocardial Ischemia in Patients With Coronary Heart Disease?

Background and Study Aims: Gastroscopy has been reported to be dangerous for unstable patients with coronary heart disease (CHD). The aims of this study were to find out whether endoscopy is equally liable to cause myocardial ischemia in stable CHD patients, and whether this can be predicted prior to endoscopy, and to find out the frequency of abnormal findings in patients for whom a secondary prophylaxis with acetylsalicylic acid (ASA) is indicated.

Patients and Methods: Electrocardiograph recording using a Holter monitor was performed during gastroscopy in 71 patients with stable CHD, to check for silent ischemia. To predict potential ischemia during gastroscopy, the Holter monitoring ECG was applied prior to a treadmill test, and withdrawn after gastroscopy 16 - 22 hours later.

Results: During gastroscopy, 30 patients (42 %) had silent ischemia, but only 1 patient (1 %) became symptomatic. Ischemia was dependent on heart-rate (median heart rate with ischemia 124 beats/min, without 104 beats/min). Abnormal findings on gastroscopy were found in 53 patients (75 %). They implied a potential bleeding risk in 30 patients (42 %) and prevented the indication for ASA in 6 of them (8 %).

Conclusions: Gastroscopy is potentially a harmful procedure for CHD patients, but the incidence of ischemic periods may be reduced by conscious sedation and, if the patient is receiving beta-blocking agent therapy, by applying this medication prior to gastroscopy.

References

• 1 Motz W. Die optimale Dosierung von Acetylsalicylsäure in der Therapie der koronaren Herzkrankheit.  Internist. 1994;  35 1165-1170
• 2 Slattery J, Warlow C P, Shorrock C J, Langman M JS. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial.  Gut. 1995;  37 509-511
• 3 Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding.  Br Med J. 1995;  310 827-830
• 4 Cappell M S. The safety and clinical utility of esophagogastroduodenoscopy for acute gastrointestinal bleeding after myocardial infarction: a six-year study of 42 endoscopies in 34 consecutive patients at two university teaching hospitals.  Am J Gastroenterol. 1993;  88 344-350
• 5 Großmann R, Börsch G, Ricken D. Kardiovaskuläre Komplikationen der gastroenterologischen Endoskopie.  Leber Magen Darm. 1987;  17 371-380
• 6 Ottenjann R, Classen M (eds). Gastroenterologische Endoskopie. Lehrbuch und Atlas. 2nd edition.  Stuttgart; Enke, 1991: 2
• 7 Heinecker R, Gonska B-D (eds). EKG in Praxis und Klinik.  Stuttgart; Thieme, 1992 52: 356-372
• 8 Lown B, Wolf M. Approaches to sudden death from coronary heart disease.  Circulation. 1971;  44 130-142
• 9 Bethge K P, Gonska B D. Langzeit-Elektrokardiographie. 3rd edition.  Berlin; Springer, 1996 24: 120
• 10 Cohn P F. Silent myocardial ischemia: classification, prevalence and prognosis.  Am J Med. 1985;  79 2-6
• 11 Sheffield L T, Holt M D, Lester F M, et al. On-line analysis of the exercise electrocardiogram.  Circulation. 1969;  40 935-944
• 12 Graham D Y, Smith J L, Spjut H J, Forres E. Gastric adaptation studies in humans during continuous aspirin administration.  Gastroenterology. 1988;  95 327-333
• 13 McEwan-Alvarado G, Barnes R N, Wallace T I. Electrocardiographic response to upper gastrointestinal endoscopy.  Am J Gastroenterol. 1972;  57 26-32
• 14 Von Arnim T. ST-Segmentanalyse im Langzeit-EKG.  Dtsch Med Wochenschr. 1985;  110 1433
• 15 Berman D S, Rozanski A, Knoebel S B. The detection of silent ischemia: cautions and precautions.  Circulation. 1987;  75 101-105
• 16 Saborowski F, Peters P, Geißler H J. ST-Strecken-Analyse bei Patienten mit Zustand nach Myokardinfarkt - ein Beitrag zur klinischen Relevanz stummer Ischämien.  Herz/Kreisl. 1989;  21 18-22
• 17 Yeung A C, Barry J, Selwyn A P. Silent ischemia after myocardial infarction. Prognosis, mechanisms, and intervention.  Circulation. 1990;  82 (suppl. II) 148
• 18 Margolis J, Kannel W, Feinleib M, et al. Clinical features of unrecognized myocardial infarction - silent and symptomatic. Eighteen-year follow-up: the Framingham Study.  Am J Cardiol. 1973;  32 1-7
• 19 Gottlieb S H, Weisfeld M L, Ouyand P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina.  N Engl J Med. 1986;  314 1214-1218
• 20 Tzivoni D, Gavish A, Zin D, et al. Prognostic significance of ischemic episodes in patients with previous myocardial infarction.  Am J Cardiol. 1988;  62 661-664
• 21 Petretta M, Bowaduce D, Bianchi V, et al. Characterization and prognostic significance of silent myocardial ischemia on predischarge electrocardiographic monitoring in unselected patients with myocardial infarction.  Am J Cardiol. 1992;  69 579-583
• 22 Fujita R, Kumura F. Arrhythmias and ischemic changes of the heart induced by gastric endoscopic procedures.  Am J Gastroenterol. 1975;  64 44-48
• 23 Rosenberg J, Overgaard H, Andersen M, et al. Double blind randomised controlled trial of effect of metroprolol on myocardial ischaemia during endoscopic cholangiopancreatography.  Br Med J. 1996;  313 258-261
• 24 Rameh B, Jabbar M, Morden A, et al. Changes in blood pressure and duodenal atony during ERCP studies of the influence of buscopan and glucagon (abstract).  Gut. 1994;  35 (Suppl. 5) 50
• 25 Geller E. Report of workshop on drugs for sedation. In: McCloy R (ed). Quality control in endoscopy. Report of an international forum held in May 1991.  Berlin; Springer, 1992: 23-27